Results 81 to 90 of about 27,638 (211)

Glycosylated LGALS3BP is highly secreted by bladder cancer cells and represents a novel urinary disease biomarker

Molecular Oncology, Volume 20, Issue 3, Page 823-837, March 2026.
Urinary LGALS3BP is elevated in bladder cancer patients compared to healthy controls as detected by the 1959 antibody–based ELISA. The antibody shows enhanced reactivity to the high‐mannose glycosylated variant secreted by cancer cells treated with kifunensine (KIF).
Asia Pece, Giulio Lovato, Ilaria Cela, Arianna Mercatelli, Benedetta Ferro, Jussi Nikkola, Sara Pagotto, Tommaso Grottola, Vincenzo De Laurenzi, Rossella Cicchetti, Antonio Marchetti, Luigi Schips, Rossano Lattanzio, Stefano Iacobelli, Emily Capone, Peter Black, Mads Daugaard, Michele Marchioni, Gianluca Sala   +18 more
wiley   +1 more source

Real-world data on utilization of neoadjuvant chemotherapy for muscle invasive bladder cancer: impact on surgical complications and oncological efficacy

Acta Oncologica
Background and purpose: Recommended treatment of urothelial muscle-invasive bladder cancer (MIBC) is cisplatin-based neoadjuvant chemotherapy (NAC) followed by cystectomy, but there are challenges with low utilization of NAC.
Hege S. Haugnes, Hakon Kjaeve, Eivind Bjerkaas, Ragnhild Hellesnes, Line Hjelle, Magnus Larsen   +5 more
doaj   +1 more source

Improving PARP inhibitor efficacy in bladder cancer without genetic BRCAness by combination with PLX51107

Molecular Oncology, Volume 20, Issue 3, Page 779-803, March 2026.
Clinical trials on PARP inhibitors in urothelial carcinoma (UC) showed limited efficacy and a lack of predictive biomarkers. We propose SLFN5, SLFN11, and OAS1 as UC‐specific response predictors. We suggest Talazoparib as the better PARP inhibitor for UC than Olaparib.
Jutta Schmitz, Anna L. Bartkowiak, Michael Rose, Nora Kolks, Patrick Petzsch, Vandana Solanki, Anne Stoffel, Bianca Faßbender, Leandra Lepping, Julka Volkamer, Karl Köhrer, Marc Seifert, Tokameh Mahmoudi, Tahlita C. M. Zuiverloon, Günter Niegisch, Michèle J. Hoffmann   +15 more
wiley   +1 more source

Use of MRI in the diagnosis of bladder cancer: a health economic analysis

BJU International, EarlyView.
Niranjan Sathianathen, Marlon Perera, Joseph Ischia, Nathan Lawrentschuk, Damien Bolton   +4 more
wiley   +1 more source

Intraoperative Evaluation of Bladder Perfusion Using Indocyanine Green Fluorescence Imaging During Total Pelvic Exenteration After Interruption of Blood Flow From the Internal Iliac Vessels

Annals of Gastroenterological Surgery, Volume 10, Issue 2, Page 543-547, March 2026.
Intraoperative ICG fluorescence imaging demonstrated that bladder perfusion was maintained through blood flow from the pubic side, even after complete division of the internal iliac vessels during total pelvic exenteration. ABSTRACT Background In lateral lymph node dissection (LLND) for locally advanced or recurrent rectal cancer, concomitant resection
Mamoru Uemura, Chikako Kusunoki, Mao Osaki, Hiroshi Kusafuka, Satoshi Higuchi, Yuki Sekido, Mitsunobu Takeda, Tsuyoshi Hata, Atsushi Hamabe, Takayuki Ogino, Norikatsu Miyoshi, Koji Munakata, Hirofumi Ota, Yuichiro Doki, Hidetoshi Eguchi   +14 more
wiley   +1 more source

Clinical outcomes of BCG‐treated patients with high‐risk non‐muscle‐invasive bladder cancer according to pre‐ and post‐2021 European Association of Urology risk classifications

BJU International, EarlyView.
Tian Ye, Benjamin Tura, Ben Abbotts, Maurice P. Zeegers, K. K. Cheng, Nicholas D. James, Richard T. Bryan   +6 more
wiley   +1 more source

Standardized care pathway reshaped the diagnostic and therapeutic landscape of urinary bladder cancer. A 15‐year population‐based study

BJUI Compass, Volume 7, Issue 3, March 2026.
Abstract Objectives This work aimed to evaluate the long‐term impact of standardized care pathway (SCP) implementation for urinary bladder cancer (UBC) on tumour characteristics, diagnostic and treatment intervals and guideline adherence. Materials and Methods A retrospective cohort study was conducted including all patients with newly diagnosed UBC at
Mansour Istamulov, Hanna Eriksson, Suleiman Abuhasanein   +2 more
wiley   +1 more source

Validation of the diagnostic accuracy of a urine‐based DNA methylation marker test in patients with upper urinary tract lesions

BJUI Compass, Volume 7, Issue 3, March 2026.
Abstract Objectives This study aims to validate the diagnostic accuracy of a novel urine‐based DNA methylation test in patients with suspected upper tract urothelial carcinoma (UTUC) on CT urography and to assess its potential to eliminate the need for diagnostic ureterorenoscopy (URS) in selected patients, expedite treatment and identify high‐grade ...
Christian Daniel Fankhauser, Kilian Röthlin, Philipp Baumeister, Agostino Mattei, Paolo Piatti, Yap Ching Chew, Ernest Kaufmann   +6 more
wiley   +1 more source

Urinary Diversion–Specific Morbidity After Radical Cystectomy: A Ten‐Year Institutional Experience

Cancer Medicine, Volume 15, Issue 3, March 2026.
ABSTRACT Introduction This study investigates the correlations and risk factors of complications associated with different urinary diversion methods after radical cystectomy (RC) for bladder cancer (BC). Methods A retrospective analysis was conducted on 574 bc patients treated between 2012 and 2022.
Xuanhan Hu, Jia Miao, Yueyu Huang, Yunkai Yang, Xinyu Zhang, Yifan Wang, Lin Qian, Dahong Zhang, Haibin Wei   +8 more
wiley   +1 more source

Effect of Surgical Findings on Prediction of Postoperative Ovarian Reserve in Patients with Ovarian Endometrioma

International Journal of Women's Health, 2022
Jisun Lee, Juyeon Kang, Hyun Jung Lee Department of Obstetrics and Gynecology, School of Medicine, Kyungpook National University, Kyungpook National University Hospital, Daegu, Republic of KoreaCorrespondence: Hyun Jung Lee, Department of Obstetrics and ...
Lee J, Kang J, Lee HJ
doaj